Your browser doesn't support javascript.
loading
Redox and Immune Signaling in Schizophrenia: New Therapeutic Potential.
Dwir, Daniella; Khadimallah, Ines; Xin, Lijing; Rahman, Meredith; Du, Fei; Öngür, Dost; Do, Kim Q.
Afiliación
  • Dwir D; Center for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital and University of Lausanne, Route de Cery, 1008 Prilly-Lausanne, Switzerland.
  • Khadimallah I; Center for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital and University of Lausanne, Route de Cery, 1008 Prilly-Lausanne, Switzerland.
  • Xin L; Center for Biomedical Imaging (CIBM), Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
  • Rahman M; Virginia Tech Carilion School of Medicine, Roanoke, Virginia, USA.
  • Du F; Psychotic Disorders Division, McLean Hospital, Harvard Medical School, Belmont, Massachusetts, USA.
  • Öngür D; Psychotic Disorders Division, McLean Hospital, Harvard Medical School, Belmont, Massachusetts, USA.
  • Do KQ; Center for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital and University of Lausanne, Route de Cery, 1008 Prilly-Lausanne, Switzerland.
Int J Neuropsychopharmacol ; 26(5): 309-321, 2023 05 31.
Article en En | MEDLINE | ID: mdl-36975001
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Esquizofrenia / Trastorno Bipolar Límite: Humans Idioma: En Revista: Int J Neuropsychopharmacol Asunto de la revista: NEUROLOGIA / PSICOFARMACOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Esquizofrenia / Trastorno Bipolar Límite: Humans Idioma: En Revista: Int J Neuropsychopharmacol Asunto de la revista: NEUROLOGIA / PSICOFARMACOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Suiza